AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It...
179 insider purchases on record · latest filing 2024-05-31.
Insiders have also filed 385 sale transactions at ATRC.